265 related articles for article (PubMed ID: 37355940)
41. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.
Kuwana M; Allanore Y; Denton CP; Distler JHW; Steen V; Khanna D; Matucci-Cerinic M; Mayes MD; Volkmann ER; Miede C; Gahlemann M; Quaresma M; Alves M; Distler O
Arthritis Rheumatol; 2022 Mar; 74(3):518-526. PubMed ID: 34514739
[TBL] [Abstract][Full Text] [Related]
42. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.
Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA;
Ann Rheum Dis; 2016 Jul; 75(7):1285-92. PubMed ID: 26232495
[TBL] [Abstract][Full Text] [Related]
43. Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud's phenomenon.
Park JS; Park MC; Song JJ; Park YB; Lee SK; Lee SW
Arthritis Res Ther; 2015 Mar; 17(1):77. PubMed ID: 25889905
[TBL] [Abstract][Full Text] [Related]
44. Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis.
Pizzorni C; Giampetruzzi AR; Mondino C; Facchiano A; Abeni D; Paolino S; Ruaro B; Smith V; Sulli A; Cutolo M
Microvasc Res; 2017 May; 111():20-24. PubMed ID: 27989404
[TBL] [Abstract][Full Text] [Related]
45. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
46. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Zanatta E; Huscher D; Ortolan A; Avouac J; Airò P; Balbir-Gurman A; Siegert E; Matucci Cerinic M; Cozzi F; Riemekasten G; Hoffmann-Vold AM; Distler O; Gabrielli A; Heitmann S; Hunzelmann N; Montecucco C; Morovic-Vergles J; Ribi C; Doria A; Allanore Y;
Rheumatology (Oxford); 2022 Nov; 61(12):4786-4796. PubMed ID: 35348643
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
[TBL] [Abstract][Full Text] [Related]
48. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and predictors of hand involvement in Thai patients with systemic sclerosis.
Wangkaew S; Sivasomboon C; Leungwatthananon W; Kasitanon N; Louthrenoo W
Int J Rheum Dis; 2018 Jan; 21(1):240-248. PubMed ID: 27456855
[TBL] [Abstract][Full Text] [Related]
50. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
51. Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival.
Tolosa-Vilella C; Del Mar Rodero-Roldán M; Guillen-Del-Castillo A; Marín-Ballvé A; Boldova-Aguar R; Marí-Alfonso B; Feijoo-Massó C; Colunga-Argüelles D; Rubio-Rivas M; Trapiella-Martínez L; Iniesta-Arandia N; Callejas-Moraga E; García-Hernández FJ; Sáez-Comet L; González-Echávarri C; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Pintó I; Chamorro AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñoz M; Fonollosa-Pla V; Simeón-Aznar CP;
Clin Exp Rheumatol; 2023 Aug; 41(8):1695-1703. PubMed ID: 37534953
[TBL] [Abstract][Full Text] [Related]
52. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
[TBL] [Abstract][Full Text] [Related]
53. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
Chong WH; Saha BK; Beegle S
Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
[TBL] [Abstract][Full Text] [Related]
54. The role of nailfold capillary dropout on mortality in systemic sclerosis.
Tieu J; Hakendorf P; Woodman RJ; Patterson K; Walker J; Roberts-Thomson P
Intern Med J; 2018 May; 48(5):517-523. PubMed ID: 29363856
[TBL] [Abstract][Full Text] [Related]
55. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort.
Foeldvari I; Klotsche J; Kasapcopur O; Adrovic A; Terreri MT; Sakamoto AP; Stanevicha V; Sztajnbok F; Anton J; Feldman B; Alexeeva E; Katsicas M; Smith V; Avcin T; Marrani E; Kostik M; Lehman T; Sifuentes-Giraldo WA; Vasquez-Canizares N; Appenzeller S; Janarthanan M; Moll M; Nemcova D; Patwardhan A; Santos MJ; Sawhney S; Schonenberg-Meinema D; Battagliotti C; Berntson L; Bica B; Brunner J; Costa-Reis P; Eleftheriou D; Harel L; Horneff G; Kaiser D; Kallinich T; Lazarevic D; Minden K; Nielsen S; Nuruzzaman F; Uziel Y; Helmus N; Torok KS
Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1575-1584. PubMed ID: 33787070
[TBL] [Abstract][Full Text] [Related]
56. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.
Ingegnoli F; Boracchi P; Gualtierotti R; Smith V; Cutolo M; Foeldvari I;
Microvasc Res; 2015 Nov; 102():19-24. PubMed ID: 26254260
[TBL] [Abstract][Full Text] [Related]
57. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
58. Anti-carbamylated protein antibodies in systemic sclerosis.
Liem SIE; Hoekstra EM; Levarht EWN; Dorjee AL; Scherer HU; Toes REM; Huizinga TWJ; de Vries-Bouwstra JK; Fehres CM
Arthritis Res Ther; 2023 Jul; 25(1):123. PubMed ID: 37480150
[TBL] [Abstract][Full Text] [Related]
59. Characterization of Venezuelan patients with systemic sclerosis: a study in a tertiary hospital in Caracas.
Rivas-Vargas D; Snih SA; Rodríguez MA
Reumatol Clin (Engl Ed); 2021 Dec; 17(10):601-606. PubMed ID: 34823828
[TBL] [Abstract][Full Text] [Related]
60. Clinical and serological features of systemic sclerosis in a Chinese cohort.
Wang J; Assassi S; Guo G; Tu W; Wu W; Yang L; Xiao R; Zhao Y; Chu H; Liu J; Ma Y; Kim SJ; Jin L; Mayes MD; Zou H; Zhou X
Clin Rheumatol; 2013 May; 32(5):617-21. PubMed ID: 23271609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
